Phenanthrene exposure produces cardiac defects during embryo development of zebrafish (Danio rerio) through activation of MMP-9

Chemosphere

Volumn 93, Issue 6, 2013, Pages 1168-1175

  Zhang, Youyu ^a   Huang, Lixing ^a   Wang, Chonggang ^a   Gao, Dongxu ^a   Zuo, Zhenghong ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

Cardiac defects; MMP 9; Phenanthrene; Zebrafish

Indexed keywords

ANTHRACENE;

AQUATIC ENVIRONMENTS; CARDIAC DEFECTS; MATRIX METALLOPROTEINASE 9 (MMP 9); MMP-9; PHENANTHRENE; PROTEIN EXPRESSION LEVELS; TRANSFORMING GROWTH FACTOR BETA; ZEBRAFISH;

HEART;

GELATINASE B; MESSENGER RNA; PHENANTHRENE; TRANSFORMING GROWTH FACTOR BETA;

AQUATIC ENVIRONMENT; DATA ACQUISITION; EMBRYO; FISH; GROWTH RATE; PHENANTHRENE; POLLUTION EXPOSURE; PROTEIN; TOXICITY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOMEGALY; CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROSING ALVEOLITIS; HEART DEVELOPMENT; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART VENTRICLE WALL; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; UPREGULATION; ZEBRA FISH;

DANIO RERIO;

CARDIAC DEFECTS; MMP-9; PHENANTHRENE; ZEBRAFISH;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; CARDIOVASCULAR ABNORMALITIES; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; MATRIX METALLOPROTEINASE 9; PHENANTHRENES; UP-REGULATION; WATER POLLUTANTS, CHEMICAL; ZEBRAFISH;

EID: 84885863417     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.06.056     Document Type: Article

References (47)

1. Albers P.H. Petroleum and individual polycyclic aromatic hydrocarbons. Handbook of Ecotoxicology 2003, 1-32. Lewis Publishers, USA. D.J. Hoffman, B.A. Rattner, G.A. Burton, J. Cairns (Eds.).
2. Billiard S.M., Timme-Laragy A.R., Wassenberg D.M., Cockman C., Di Giulio R.T. The role of the aryl hydrocarbon receptor pathway in mediating synergistic developmental toxicity of polycyclic aromatic hydrocarbons to zebrafish. Toxicol. Sci. 2006, 92:526-536.
3. Cai J.L., Wang M.M., Li B.W., Wang C.G., Chen Y.X., Zuo Z.H. Apoptotic and necrotic action mechanisms of trimethyltin in human hepatoma G2 (HepG2) cells. Chem. Res. Toxicol. 2009, 22:1582-1587.
4. Carls M.G., Heintz R.A., Marty G.D., Rice S.D. Cytochrome P4501A induction in oil-exposed pink salmon Oncorhynchus gorbuscha embryos predicts reduced survival potential. Mar. Ecol. Prog. Ser. 2005, 301:253-265.
5. Chen B., Xuan X., Zhu L., Wang J., Gao Y., Yang K. Distribution of polycyclic aromatic hydrocarbons in surface waters, sediments and soils of Hangzhou City, China. Water. Res. 2004, 38:16.
6. Chen Z.Y., Huang W., Dahme T., Rottbauer W., Ackerman M.J., Xu X.L. Depletion of zebrafish essential and regulatory myosin light chains reduces cardiac function through distinct mechanisms. Cardiovasc. Res. 2008, 79:97-108.
7. Ducharme A., Frantz S., Aikawa M., Rabkin E., Lindsey M., Rohde L.E., Schoen F.J., Kelly R.A., Werb Z., Libby P., Lee R.T. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 2000, 106(1):55-62.
8. Etoh T., Joffs C., Deschamps A.M., Davis J., Dowdy K., Hendrick J., Baicu S., Mukherjee R., Manhaini M., Spinale F.G. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. Am. J. Physiol - Heart. C. 2001, 281:H987-H994.
9. Gearing A.J.H., Beckett P., Christodoulou M., Churchill M., Clements J., Davidson A.H., Drummond A.H., Galloway W.A., Gilbert R., Gordon J.L., Leber T.M., Mangan M., Miller K., Nayee P., Owen K., Patel S., Thomas W., Wells G., Wood L.M., Woolley K. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994, 370(6490):555-557.
10. Halsall C.J., Coleman P.J., Davis B.J., Burnett V., Waterhouse K.S., Hardingjones P., Jones K.C. Polycyclic aromatic hydrocarbons in UK urban air. Environ. Sci. Technol. 1994, 28:2380-2386.
11. Heintz R.A., Rice S.D., Wertheimer A.C., Bradshaw R.F., Thrower F.P., Joyce J.E., Short J.W. Delayed effects on growth and marine survival of pink salmon Oncorhynchus gorbuscha after exposure to crude oil during embryonic development. Mar. Ecol. Prog. Ser. 2000, 208:205-216.
12. Hendon L.A., Carlson E.A., Manning S., Brouwe M. Molecular and developmental effects of exposure to pyrene in the early life-stages of Cyprinodon variegates. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. 2008, 147:205-215.
13. Heymans S., Luttun A., Nuyens D., Theilmeier G., Creemers E., Moons L., Dyspersin G.D., Cleutjens J.P., Shipley M., Angellilo A., Levi M., Nübe O., Baker A., Keshet E., Lupu F., Herbert J.M., Smits J.F., Shapiro S.D., Bases M., Borgers M., Collen D., Daemen M.J., Carmeliet P. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat. Med. 1999, 5:1135-1142.
14. Huang L.X., Wang C.G., Zhang Y.Y., Li J., Zhong Y.F., Zhou Y.L., Chen Y.X., Zuo Z.H. Benzo[a]pyrene exposure influences the cardiac development and the expression of cardiovascular relative genes in zebrafish (Danio rerio) embryos. Chemosphere 2012, 87(4):369-375.
15. Incardona J.P., Carls M.G., Day H.L., Sloan C.A., Bolton J.L., Collier T.K., Scholz N.L. Cardiac arrhythmia is the primary response of embryonic Pacific herring (Clupea pallasi) exposed to crude oil during weathering. Environ. Sci. Technol. 2009, 43:201-207.
16. Incardona J.P., Collier T.K., Scholz N.L. Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 2004, 196:191-205.
17. Incardona J.P., Carls M.G., Teraoka H., Sloan C.A., Collier T.K., Scholz N.L. Aryl hydrocarbon receptor-independent toxicity of weathered crude oil during fish development. Environ. Health Perspect. 2005, 113:1755-1762.
18. Incardona J.P., Day H.L., Collier T.K., Scholz N.L. Developmental toxicity of 4-ring polycyclic aromatic hydrocarbons in zebrafish is differentially dependent on AH receptor isoforms and hepatic cytochrome P450 1A metabolism. Toxicol. Appl. Pharmacol. 2006, 217:308-321.
19. Kuwahara F., Kai H., Tokuda K., Kai M., Takeshita A., Egashira K., Imaizumi T. Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002, 106:130-135.
20. Li R.X., Zuo Z.H., Chen D.L., He C.Y., Chen R., Chen Y.X., Wang C.G. Inhibition by polycyclic aromatic hydrocarbons of ATPase activities in Sebastiscus marmoratus larvae: relationship with the development of early life stages. Mar. Environ. Res. 2011, 71:86-90.
21. Li Y.Y., McTiernan C.F., Feldman A.M. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc. Res. 2000, 46:214-224.
22. Maskaoui K., Zhou J.L., Hong H.S., Zhang Z.L. Contamination by polycyclic aromatic hydrocarbons in the Jiulong river estuary and western Xiamen Sea, China. Environ. Pollut. 2002, 118:109-122.
23. Moshal K.S., Rodriguez W.E., Sen U., Tyagi S.C. Targeted deletion of MMP-9 attenuates myocardial contractile dysfunction in heart failure. Physiol. Res. 2008, 57:379-384.
24. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274:21491-21494.
25. National Research Council Oil in the Sea III: Inputs, Fates, and Effects 2003, National Academies Press, Washington, DC.
26. Nieto M.A., Patel K., Wilkinson D.G. In situ hybridization analysis of chick embryos in whole mount and tissue sections. Methods Cell Biol. 1996, 51:219-235.
27. Nishikawa N., Yamamoto K., Sakata Y., Mano T., Yoshida J., Miwa T., Takeda H., Hori M., Masuyama T. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Cardiovasc. Res. 2003, 57:766-774.
28. Patterson B.C., Sang Q.A. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 1997, 272(46):28823-28825.
29. Pauschinger M., Knopf D., Petschauer S., Doerner A., Poller W., Schwimmbeck P.L., Kühl U., Schultheiss H.P. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 1999, 99:2750-2756.
30. Peterson R.E., Theobald H.M., Kimmel G.L. Developmental and reproductive toxicity of dioxins and related compounds: cross-species comparisons. Crit. Rev. Toxicol. 1993, 23:283-335.
31. Peterson J.T., Li H., Dillon L., Bryant J.W. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc. Res. 2000, 46:307-315.
32. Petrov V.V., Fagard R.H., Lijnen P.J. Transforming growth factor-β1 induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts. J. Renin. Angiotensin. Aldosterone. Syst. 2000, 1:342.
33. Sanderson J.E., Lai K.B., Shum I.O.L., Wei S., Chow L.T.C. Transforming growth factor-β1 expression in dilated cardiomyopathy. Heart 2001, 86:701-708.
34. Sivakumar P., Gupta S., Sarkar S., Sen S. Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy. Mol. Cell. Biochem. 2008, 307:159-167.
35. Spinale F.G., Coker M.L., Thomas C.V., Walker J.D., Mukherjee R., Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ. Res. 1998, 82:482-495.
36. Spinale F.G., Coker M.L., Bond B.R., Zellner J.L. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Cardiovasc. Res. 2000, 46:225-238.
37. Spinale F.G., Coker M.L., Heung L.J., Bond B.R., Gunasinghe H.R., Etoh T., Goldberg A.T., Zellner J.L., Crumbley A.J. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 2000, 102(16):1944-1949.
38. Sung M.M., Schulz C.G., Wang W.J., Sawicki G., Bautista-López N.L., Schulz R. Matrix metalloproteinase-2 degrades the cytoskeletal protein α-actinin in peroxynitrite mediated myocardial injury. J. Mol. Cell. Cardiol. 2007, 43:429-436.
39. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 2002, 37(6):375-536.
40. Villarreal F.J., Dillmann W.H. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin and collagen. Am. J. Physiol. 1992, 262:H1861-H1866.
41. Westerfield M. The Zebrafish Book. A guide for the laboratory use of zebrafish (Danio rerio) 2000, University of Oregon Press, Eugene.
42. Woessner J.F., Nagase H. Matrix Metalloproteinases and TIMPs 2000, Oxford University Press, New York.
43. Xiao H., Ma X.W., Feng W., Fu Y.N., Lu Z.Z., Xu M., Shen Q., Zhu Y., Zhang Y.Y. Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1-Smad3 signalling pathway. Cardiovasc. Res. 2010, 87:504-513.
44. Xie Z.L., Singh M., Singh K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1β. J. Biol. Chem. 2004, 279:39513-39519.
45. Yang L., Yang L.X., Ho N.Y., Müller F., Strähle U. Methyl mercury suppresses the formation of the tail primordium in developing zebrafish embryos. Toxicol. Sci. 2010, 115(2):379-390.
46. Yoshikane H., Honda M., Goto Y., Morioka S., Ooshima A., Moriyama K. Collagen in dilated cardiomyopathy: scanning electron microscopic and immunohistochemical observations. Jpn. Circ. J. 1992, 56:899-910.
47. Zhang Y.Y., Wang C.G., Huang L.X., Chen R., Chen Y.X., Zuo Z.H. Low-level pyrene exposure causes cardiac toxicity in zebrafish (Danio rerio) embryos. Aquat. Toxicol. 2012, 114-115:119-124.